Regent Pacific Group 575.HK · HKD

Its shares trade on HKEX under the ticker 575.HK. It has been listed since 19 May 1997. In the fiscal year to 31 December 2024, it reported revenue of $804,000 and a net loss of $4.5m.

Regent Pacific Group Ltd. is an investment holding company. The company employs 19 full-time employees The firm operates through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sales of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The firm is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. The company offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Jamie GibsonChief Executive Officer, Executive Director, since 2002$1.8m
• Mr. Yui Fui WongChief Financial Officer
• Mr. Michael WyllieChief Scientific Officer
• Mr. David ChurchHead of Mergers and Acquisitions, General Counsel
• Mr. Paul JonesInvestment Director
• Ms. Mei Yan LuiCompany Secretary
• Mrs. Jayne SutcliffeNon-Executive Director, since 2000$25,000
• Mr. Ihsan ChalabiNon-Executive Independent Director
• Mr. Wan Tsun ChanIndependent Non-Executive Director
• Mr. Stawell SearleIndependent Non-Executive Director$39,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.